Affiliation:
1. From the Molecular Cardiology Research Institute (G.P., R.H.K., M.A., M.E.M.), New England Medical Center, Boston, Mass; and Institut de Génétique et de Biologie Moléculaire et Cellulaire (A.K., S.D., P.C.), CNRS/INSERM/ULP, Collège de France, Illkirch Cedex, France.
Abstract
Blood vessel cells express the 2 known estrogen receptors, α and β (ERα, ERβ), which are thought to mediate estrogen inhibition of vascular injury and atherosclerosis, but the relative role of ERα and ERβ in these events is controversial. Estrogen inhibits the vascular injury response to the same extent in ovariectomized female wild-type mice and in the original single gene knockout mice for ERα (ERαKO
Chapel Hill
[ERαKO
CH
]) and ERβ (ERβKO
Chapel Hill
[ERβKO
CH
]). In double gene knockout mice generated by crossing these animals (ERα,βKO
CH
), estrogen no longer inhibits medial thickening after vascular injury, but still inhibits vascular smooth muscle cell proliferation and increases uterine weight. The partial retention of estrogen responsiveness in ERα,βKO
CH
mice could be due either to the presence of a novel, unidentified estrogen receptor or to functional expression of an estrogen receptor-α splice variant in the parental ERαKO
CH
mice. To distinguish between these possibilities, we studied recently generated mice fully null for estrogen receptor α (ERαKO
Strasbourg
[ERαKO
St
]) and examined the effect of estrogen on the response to vascular injury. In the present study, we show that after vascular injury in ovariectomized ERαKO
St
mice, estrogen has no detectable effect on any measure of vascular injury, including medial area, proteoglycan deposition, or smooth muscle cell proliferation. These data demonstrate that estrogen receptor-α mediates the protective effects of estrogen on the response to vascular injury.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Cited by
325 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献